GUGGENHEIM CAPITAL LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 85 filers reported holding CTI BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$25,000
+4.2%
63,0170.0%0.00%
Q3 2016$24,000
+9.1%
63,017
-0.9%
0.00%
Q2 2016$22,000
-38.9%
63,588
-6.7%
0.00%
Q1 2016$36,000
-39.0%
68,146
+42.9%
0.00%
Q4 2015$59,0000.0%47,695
+18.2%
0.00%
Q3 2015$59,000
-28.9%
40,362
-4.5%
0.00%
Q2 2015$83,000
+13.7%
42,283
+4.4%
0.00%
Q1 2015$73,000
-3.9%
40,504
+26.1%
0.00%
Q4 2014$76,000
+13.4%
32,123
+17.3%
0.00%
Q3 2014$67,000
-65.1%
27,378
-59.8%
0.00%
Q2 2014$192,00068,1880.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2014
NameSharesValueWeighting ↓
EAGLE ASSET MANAGEMENT INC 15,707,022$38,010,0000.11%
First Heartland Consultants, Inc. 74,624$181,0000.08%
WASHINGTON TRUST Co 410,616$994,0000.07%
Geduld E E 40,000$97,0000.07%
FIRST NEW YORK SECURITIES LLC /NY 30,562$73,960,0000.05%
Crosspoint Capital Strategies, LLC 25,000$61,0000.04%
JANE STREET GROUP, LLC 1,434,975$3,473,0000.04%
MAGEE THOMSON INVESTMENT PARTNERS LLC 21,479$51,0000.01%
TIAA CREF TRUST CO FSB/MO 296,322$717,0000.01%
Investors Capital Advisory Services 16,950$41,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders